-
Published23/04/2025
-
Today18/05/2025
-
Deadline31/05/2027
-
Opening of tenders31/05/2027
Utilities
- indicates text translated automatically in your browsing language
Open House Biologics Discount Contracts 2025-10 - Choriongonadotropin alfa Text automatically translated in your browsing language Automatically translated
TK pursues the objective of concluding rebate agreements with all suitable pharmaceutical companies in accordance with Paragraph 130a(8) of Book V of the Social Code on the active substance chorionic gonadotropin alfa. The contract is concluded within the framework of the TK's open-house procedure: Individual negotiations on contract contents are not conducted, uniform conditions apply. TK does not guarantee any exclusivity to individual contractual partners. The contract duration is a maximum of 24 months starting from 01.06.2025. The contract ends at the latest on 31.05.2027, regardless of the date of conclusion of the contract. All further information can be found in the participation and contract documents. Text automatically translated in your browsing language Automatically translated
tdf-non-av
HEK - Hanseatische Krankenkasse
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.